Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)
Egypt flag Egypt · Delayed Price · Currency is EGP
700.00
-7.84 (-1.11%)
At close: Oct 1, 2025

EGX:AXPH Revenue

In the fiscal year ending June 30, 2025, Alexandria Co. For Pharmaceuticals & Chemical Industries had annual revenue of 2.75B EGP with 55.56% growth. Alexandria Co. For Pharmaceuticals & Chemical Industries had revenue of 261.99M in the quarter ending June 30, 2024, a decrease of -30.20%.

Revenue
2.75B
Revenue Growth
+68.97%
P/S Ratio
1.27
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.50B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20252.75B982.44M55.56%
Jun 30, 20241.77B283.76M19.12%
Jun 30, 20231.48B384.31M34.94%
Jun 30, 20221.10B-4.24M-0.38%
Jun 30, 20211.10B79.44M7.75%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition